TDC
ELOS

Thompson Davis & Co’s Syneron Medical Ltd ELOS Stock Holding History

Thompson Davis & Co’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,250
Closed -$87K – 1266
2017
Q1 		$87K Sell
8,250
-4,750
-37% -$45.9K 0.12% 163
2016
Q4 		$109K Buy
+13,000
New +$102K 0.18% 124
2015
Q3 		– Sell
-250
Closed -$3K – 1315
2015
Q2 		$3K Buy
+250
New +$2.93K ﹤0.01% 1045

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Thompson Davis & Co's ELOS Position: Q2 2017 in Review

Thompson Davis & Co sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 8,250 shares — an estimated $87K sold.

Thompson Davis & Co first reported a position in ELOS in Q2 2015 and held it in 3 quarters. The position peaked at $109K in Q4 2016. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • Thompson Davis & Co reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 8,250 Syneron Medical Ltd shares in Q2 2017, an estimated $87K.
  • Thompson Davis & Co first reported a position in Syneron Medical Ltd in Q2 2015 and held it in 3 quarters.
  • Thompson Davis & Co's Syneron Medical Ltd position peaked at $109K in Q4 2016.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Thompson Davis & Co's 13F filing for Q2 2017, filed 10 Aug 2017.